Herrero, Rolando
Fantin, Romain
Loría, Viviana
Aparicio, Amada
Prevots, D. Rebecca
Zúñiga, Michael
Wong, Roy
Morera, Melvin
Butt, Julia
Binder, Marco
Abdelnour, Arturo
Calderón, Alejandro
Castro, Roberto
Cortes, Bernal
Ocampo, Rebeca
Vanegas, Juan Carlos
Gail, Mitchell H.
Pfeiffer, Ruth M.
Flock, Julia
Remans, Kim
Eberhardt, Lukas
Rastgou, Soheil
Magalhaes, Vladimir
Porras, Carolina
Hildesheim, Allan
Waterboer, Tim
,
Funding for this research was provided by:
National Cancer Institute, United States
Ministerio de Ciencia y Tecnologia, Costa Rica
Funidacion INCIENSA, Costa rica
National Institute of Allergy and Infectious Diseases
Article History
Received: 12 June 2024
Accepted: 3 March 2025
First Online: 18 March 2025
Declarations
:
: The RESPIRA study was approved by the Ethical Committee of the Costa Rican Social Security Administration (Caja Costarricense de Seguro Social), protocol #R020-SABI-00261. The committee is authorized and supervised by the National Research Council (CONIS) of the Ministry of Health of Costa Rica under Research Law number 9234 of April 2014. The research was conducted in compliance with all local regulations and the Declaration of Helsinki. All participants, or their parents in the case of minors, signed informed consent forms approved by the ethical committee. Children between 12 and 17 additionally signed informed assent forms. The signature was performed in the presence of a witness who was not part of the study staff, according to the Costa Rican research law.
: Not applicable.
: The authors declare no competing interests.